192 related articles for article (PubMed ID: 22791446)
21. [Comparison of two kinds of cationic vectors-mediated gene delivery].
Zhi DF; Wang B; Cui SH; Yang BL; Zhao BD; Zhao YN; Jiang YX; Yu SJ; Zhang SB
Yao Xue Xue Bao; 2009 May; 44(5):553-7. PubMed ID: 19618735
[TBL] [Abstract][Full Text] [Related]
22. Optimization of a new non-viral vector for transfection: Eudragit nanoparticles for the delivery of a DNA plasmid.
Gargouri M; Sapin A; Bouli S; Becuwe P; Merlin JL; Maincent P
Technol Cancer Res Treat; 2009 Dec; 8(6):433-44. PubMed ID: 19925027
[TBL] [Abstract][Full Text] [Related]
23. Cholesterol domains in cationic lipid/DNA complexes improve transfection.
Xu L; Anchordoquy TJ
Biochim Biophys Acta; 2008 Oct; 1778(10):2177-81. PubMed ID: 18489900
[TBL] [Abstract][Full Text] [Related]
24. Lipid peptide nanocomplexes for gene delivery and magnetic resonance imaging in the brain.
Writer MJ; Kyrtatos PG; Bienemann AS; Pugh JA; Lowe AS; Villegas-Llerena C; Kenny GD; White EA; Gill SS; McLeod CW; Lythgoe MF; Hart SL
J Control Release; 2012 Sep; 162(2):340-8. PubMed ID: 22800579
[TBL] [Abstract][Full Text] [Related]
25. Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides.
Weng A; Manunta MD; Thakur M; Gilabert-Oriol R; Tagalakis AD; Eddaoudi A; Munye MM; Vink CA; Wiesner B; Eichhorst J; Melzig MF; Hart SL
J Control Release; 2015 May; 206():75-90. PubMed ID: 25758332
[TBL] [Abstract][Full Text] [Related]
26. Lipopolyplex ternary delivery systems incorporating C14 glycerol-based lipids.
Kudsiova L; Fridrich B; Ho J; Mustapa MF; Campbell F; Welser K; Keppler M; Ng T; Barlow DJ; Tabor AB; Hailes HC; Lawrence MJ
Mol Pharm; 2011 Oct; 8(5):1831-47. PubMed ID: 21815622
[TBL] [Abstract][Full Text] [Related]
27. [Transfection efficiency comparison of cationic liposome-DNA complexes and lipid-protamine-DNA complexes in vitro].
Sun X; Tian L; Nie Y; Zhang Z; Lu J; Wei Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):191-5. PubMed ID: 17333920
[TBL] [Abstract][Full Text] [Related]
28. Solid lipid nanoparticles: formulation factors affecting cell transfection capacity.
del Pozo-Rodríguez A; Delgado D; Solinís MA; Gascón AR; Pedraz JL
Int J Pharm; 2007 Jul; 339(1-2):261-8. PubMed ID: 17467205
[TBL] [Abstract][Full Text] [Related]
29. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
[TBL] [Abstract][Full Text] [Related]
30. Structures of lipid-DNA complexes: supramolecular assembly and gene delivery.
Safinya CR
Curr Opin Struct Biol; 2001 Aug; 11(4):440-8. PubMed ID: 11495736
[TBL] [Abstract][Full Text] [Related]
31. New gene delivery system based on oligochitosan and solid lipid nanoparticles: 'in vitro' and 'in vivo' evaluation.
Delgado D; del Pozo-Rodríguez A; Angeles Solinís M; Bartkowiak A; Rodríguez-Gascón A
Eur J Pharm Sci; 2013 Nov; 50(3-4):484-91. PubMed ID: 23981333
[TBL] [Abstract][Full Text] [Related]
32. The enhancement of transfection efficiency of cationic liposomes by didodecyldimethylammonium bromide coated gold nanoparticles.
Li D; Li G; Li P; Zhang L; Liu Z; Wang J; Wang E
Biomaterials; 2010 Mar; 31(7):1850-7. PubMed ID: 19945155
[TBL] [Abstract][Full Text] [Related]
33. Lipopolyplexes as nanomedicines for therapeutic gene delivery.
García L; Urbiola K; Düzgüneş N; Tros de Ilarduya C
Methods Enzymol; 2012; 509():327-38. PubMed ID: 22568913
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes.
Hyndman L; Lemoine JL; Huang L; Porteous DJ; Boyd AC; Nan X
J Control Release; 2004 Oct; 99(3):435-44. PubMed ID: 15451601
[TBL] [Abstract][Full Text] [Related]
35. Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration.
del Pozo-Rodríguez A; Delgado D; Solinís MA; Pedraz JL; Echevarría E; Rodríguez JM; Gascón AR
Int J Pharm; 2010 Jan; 385(1-2):157-62. PubMed ID: 19835940
[TBL] [Abstract][Full Text] [Related]
36. Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles.
Caracciolo G; Cardarelli F; Pozzi D; Salomone F; Maccari G; Bardi G; Capriotti AL; Cavaliere C; Papi M; Laganà A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13171-9. PubMed ID: 24245615
[TBL] [Abstract][Full Text] [Related]
37. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
38. Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes.
Jain S; Kumar S; Agrawal AK; Thanki K; Banerjee UC
Mol Pharm; 2013 Jun; 10(6):2416-25. PubMed ID: 23597269
[TBL] [Abstract][Full Text] [Related]
39. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
[TBL] [Abstract][Full Text] [Related]
40. Lipid nanoparticles for gene delivery.
Zhao Y; Huang L
Adv Genet; 2014; 88():13-36. PubMed ID: 25409602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
